ask="N/A"
ask_size="N/A"
average_daily_volume="336392"
bid="N/A"
bid_size="N/A"
book_value="0.3390"
change="-0.0201"
change_from_200_day_moving_average="-0.0304"
change_from_50_day_moving_average="0.0263"
change_from_52_week_high="-3.4601"
change_From_52_week_low="0.5299"
change_in_percent="-1.2108%"
close="1.6399"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.4870"
ebitda="-12.32M"
eps_estimate_current_year="-1.5800"
eps_estimate_next_quarter="-0.3600"
eps_estimate_next_year="-0.8800"
ex_dividend_date="N/A"
float_shares="3683000"
high="1.6900"
high_52_weeks="5.1000"
last_trade_date="2/17/2017"
last_trade_price="1.6399"
last_trade_size="200"
last_trade_time="3:59pm"
low="1.5800"
low_52_weeks="1.1100"
market_capitalization="15.72M"
moving_average_200_day="1.6703"
moving_average_50_day="1.6136"
name="Eyegate Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="10.0000"
open="1.6400"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-1.8183%"
percent_change_from_50_day_moving_average="+1.6286%"
percent_change_from_52_week_high="-67.8451%"
percent_change_from_52_week_low="+47.7387%"
previous_close="1.6600"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.8968"
price_per_sales="31.2663"
revenue="508889.00"
shares_outstanding="9585000"
short_ratio="0.7600"
stock_exchange="NCM"
symbol="EYEG"
volume="58813"
weeks_range_52="1.1100 - 5.1000"
